Microbubbles as ultrasound contrast agents and in targeted drug delivery

Critical Reviews in Biomedical Engineering

Volumn 36, Issue 4, 2008, Pages 235-265

  Sheffield, Peter ^a,b   Trehan, Aastha ^b   Boyd, Brendan ^a,b   Wong, Oi Lei ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Cancer; Cavitation; Contrast; Drug delivery; Imaging; Microbubble; Microsphere; Oscillation; Ultrasound

Indexed keywords

CAVITATION; DIAGNOSIS; DISEASES; DRUG DELIVERY; IMAGING TECHNIQUES; MICROSPHERES; ULTRASONICS;

BLOOD-BRAIN BARRIER; CANCER; CONTRAST; DIAGNOSTIC ULTRASOUND; MEDICAL ULTRASOUND; MICRO-BUBBLE; OSCILLATION; ULTRASOUND CONTRAST AGENT;

TARGETED DRUG DELIVERY;

ECHO CONTRAST MEDIUM;

BIOSAFETY; BLOOD BRAIN BARRIER; BREAST TUMOR; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DOPPLER ECHOGRAPHY; DRUG DELIVERY SYSTEM; GENE THERAPY; HUMAN; IMAGE ANALYSIS; LIVER FIBROSIS; MICROBUBBLE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW;

EID: 71449100604     PISSN: 0278940X     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevBiomedEng.v36.i4.10     Document Type: Review

References (45)

1. Calliada F, Campani R, Bottinelli O, Bozzini A, Sommaruga MG. Ultrasound contrast agents: basic principles. Eur J Radiol. 1998 May;27 Suppl 2:S157-60. (Pubitemid 28270589)
2. Unger EC, Porter T, Culp W, Labell R, Matsunaga T, Zutshi R. Therapeutic applications of lipid-coated microbubbles. Adv Drug Deliv Rev. 2004 May 7;56(9):1291-1314
3. Cosgrove D, Eckersley R. Contrastenhanced ultrasound: basic physics and technology overview. In: Lencioni R, editor. Enhancing the role of Ultrasound with Contrast Agents. Berlin: Springer-Verlag; 2006. p. 3-14.
4. Raisinghani A, Rafter P, Phillips P, Vannan MA, DeMaria AN. Microbubble contrast agents for echocardiography: rationale, composition, ultrasodund interactions, and safety. Cardiol Clin. 2004 5;22(2):171-180
5. Grayburn PA. Current and future contrast agents. Echocardiography (Mount Kisco, NY). 2002 Apr;19(3):259-265
6. Klibanov AL. Microbubbles: ultrasound contrast agents for molecular imaging. In: Bulte JWM, Modo MMJ, editors. Nanoparticles in biomedical imaging: emerging technologies and applications. New York, NY: Springer Science+Business Media, LLC; 2008. p. 327-341
7. Liu Y, Miyoshi H, Nakamura M. Encapsulated ultrasound microbubbles: therapeutic application in drug/gene delivery. J Control Release. 2006 Aug 10;114(1):89-99.
8. Pitt WG, Husseini GA, Staples BJ. Ultrasonic drug delivery-a general review. Expert Opin Drug Deliv. 2004 Nov;1(1):37-56.
9. Blomley MJ, Cooke JC, Unger EC, Monaghan MJ, Cosgrove DO. Microbubble contrast agents: a new era in ultrasound. BMJ. 2001 May 19;322(7296):1222-1225
10. Hauff P, Reinhardt M, Foster S. Ultrasound basics. Handb Exp Pharmacol. 2008;185 Pt 1:91-107.
11. Gramiak R, Shah PM. Echocardiography of the aortic root. Invest Radiol. 1968 Sep-Oct;3(5):356-366
12. Mayer S, Grayburn PA. Myocardial contrast agents: recent advances and future directions. Prog Cardiovasc Dis. 2001 Jul-Aug;44(1):33-44.
13. May DJ, Allen JS, Ferrara KW. Dynamics and fragmentation of thickshelled microbubbles. IEEE UFFC. 2002;49(10):1400-1410
14. Quaia E. Microbubble ultrasound contrast agents: an update. Eur Radiol. 2007 Aug;17(8):1995-2008.
15. Maresca G, Summaria V, Colagrande C, Manfredi R, Calliada F. New prospects for ultrasound contrast agents. Eur J Radiol. 1998 May;27 Suppl 2:S171-8. (Pubitemid 28270591)
16. Ferrara K, Pollard R, Borden M. Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng. 2007;9:415-447
17. Guidelines for the Safe Use of Diagnostic Ultrasound. Health Canada; 2001.
18. Miller DL, Averkiou MA, Brayman AA, Everbach EC, Holland CK, Wible JJH, Wible JH, Jr. Bioeffects considerations for diagnostic ultrasound contrast agents. J Ultrasound Med. 2008 Apr;27(4):611-32; quiz 633-636
19. Lindner JR. Microbubbles in medical imaging: current applications and future directions. Nat Rev Drug Discov. 2004 Jun;3(6):527-532
20. Kim TK, Jang HJ, Wilson SR. Benign liver masses: imaging with microbubble contrast agents. Ultrasound Q. 2006 Mar;22(1):31-39
21. Quaia E, Bertolotto M, Cioffi V, Rossi A, Baratella E, Pizzolato R, Cov MA. Comparison of contrast-enhanced sonography with unenhanced sonography and contrast-enhanced CT in the diagnosis of malignancy in complex cystic renal masses. Am J Roentgenol. 2008 Oct;191(4):1239-1249
22. Correas JM, Claudon M, Tranquart F, Helenon AO. The kidney: imaging with microbub- ble contrast agents. Ultrasound Q. 2006 Mar;22(1):53-66.
23. Dijkmans PA, Juffermans LJ, Musters RJ, van Wamel A, ten Cate FJ, van Gilst W, Visser CA, de Jong N, Kamp O. Microbubbles and ultrasound: from diagnosis to therapy. Eur J Echocardiogr. 2004 Aug;5(4):245-256
24. Tachibana K, Tachibana S. The use of ultrasound for drug delivery. Echocardiography. 2001 May;18(4):323-328
25. Taniyama Y, Tachibana K, Hiraoka K, Namba T, Yamasaki K, Hashiya N, Aoki M, Ogihara T, Yasufumi K, Morishita R. Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation. 2002 Mar 12;105(10):1233-1239
26. Lu QL, Liang HD, Partridge T, Blomley MJ. Microbubble ultrasound improves the efficiency of gene transduction in skeletal muscle in vivo with reduced tissue damage. Gene Ther. 2003 Mar;10(5):396-405.
27. Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci. 2001 Sep;14(2):101-114.
28. Mitragotri S, Kost J. Low-frequency sonophoresis: a review. Adv Drug Deliv Rev. 2004 Mar 27;56(5):589-601.
29. Kwok CS, Mourad PD, Crum LA, Ratner BD. Self-assembled molecular structures as ultrasonically-responsive barrier membranes for pulsatile drug delivery. J Biomed Mater Res. 2001 Nov;57(2):151-164
30. Hynynen K, McDannold N, Martin H, Jolesz FA, Vykhodtseva N. The threshold for brain damage in rabbits induced by bursts of ultrasound inthe presence of an ultrasound contrast agent (Optison). Ultrasound Med Biol. 2003 Mar;29(3):473-481
31. McDannold N, Vykhodtseva N, Hynynen K. Targeted disruption of the blood-brain barrier with focused ultrasound: association with cavitation activity. Phys Med Biol. 2006 Feb 21;51(4):793-807.
32. Bakay L, Ballantine JHT, Hueter TF, Sosa D. Ultrasonically produced changes in the blood-brain barrier. Arch Neurol. 1956 Nov;76(5):457-467
33. Bakay L, Ballantine JHT, Bell E. P32 uptake by normal and ultrasonically irradiated brain tissue from cerebrospinal uid. Arch Neurol. 1959 Jul;1:59-67.
34. Ballantine JHT, Bell E, Manlapaz J. Progress and problems in the neurological appli- cations of focused ultrasound. J Neurosurg. 1960 Sep;17:858-876
35. Hynynen K, McDannold N, Sheikov NA, Jolesz FA, Vykhodtseva N. Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. Neuroimage. 2005 Jan 1;24(1):12-20.
36. Baselga J. Current and planned clinical trials with trastuzumab (Herceptin). Semin Oncol. 2000 Oct;27(5 Suppl 9):27-32. (Pubitemid 30778331)
37. Sheikov N, McDannold N, Jolesz F, Zhang YZ, Tam K, Hynynen K. Brain arterioles show more active vesicular transport of blood-borne tracer molecules than capillaries and venules after focused ultrasoundevoked opening of the blood-brain barrier. Ultrasound Med Biol. 2006 Sep;32(9):1399-2109
38. Tinkov S, Bekeredjian R, Winter G, Coester C. Microbubbles as ultrasound triggered drug carriers. J Pharm Sci. 2009 Jun;98(6):1935-1961
39. Yamaya Y, Niizeki K, Kim J, Entin PL, Wagner H, Wagner PD. Effects of Optison on pulmonary gas exchange and hemodynamics. Ultrasound Med Biol. 2002 Aug;28(8):1005-1013
40. Miller DL, Li P, Dou C, Gordon D, Edwards CA, Armstrong WF. In uence of contrast agent dose and ultrasound exposure on cardiomyocyte injury induced by myocardial contrast echocardiography in rats. Radiology. 2005 Oct;237(1):137-143 (Pubitemid 41346157)
41. Chapman S, Windle J, Xie F, McGrain A, Porter TR. Incidence of cardiac arrhythmias with therapeutic versus diagnostic ultrasound and intravenous microbubbles. J Ultrasound Med. 2005 Aug;24(8):1099-1107
42. Sakakima Y, Hayashi S, Yagi Y, Hayakawa A, Tachibana K, Nakao A. Gene therapy for hepatocellular carcinoma using sonoporation enhanced by contrast agents. Cancer Gene Ther. 2005 Nov;12(11):884-889
43. Miao CH, Brayman AA, Loeb KR, Ye P, Zhou L, Mourad P, Crum LA. Ultrasound enhances gene delivery of human factor IX plasmid. Human Gene Therapy. 2005 Jul;16(7):893-905.
44. Apfel RE, Holland CK. Gauging the likelihood of cavitation from short-pulse, low-duty cycle diagnostic ultrasound. Ultrasound Med Biol. 1991;17(2):179-185
45. Xian X, Lin S. Study on the compound multifrequency ultrasonic transducer in exural vibration. Ultrasonics. 2008 Jul;48(3):202-208